Exact Sciences Corporation (EXAS)
USD 43.1
(3.66%)
USD 43.1
(3.66%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.47 Billion USD | 3.93% |
| 2022 | 6.22 Billion USD | -6.85% |
| 2021 | 6.68 Billion USD | 35.73% |
| 2020 | 4.92 Billion USD | 40.49% |
| 2019 | 3.5 Billion USD | 130.03% |
| 2018 | 1.52 Billion USD | 154.61% |
| 2017 | 598.56 Million USD | 58.75% |
| 2016 | 377.04 Million USD | 3.5% |
| 2015 | 364.29 Million USD | 16.9% |
| 2014 | 311.62 Million USD | 112.53% |
| 2013 | 146.62 Million USD | 30.78% |
| 2012 | 112.11 Million USD | 15.64% |
| 2011 | 96.95 Million USD | 0.45% |
| 2010 | 96.51 Million USD | 274.52% |
| 2009 | 25.77 Million USD | 336.93% |
| 2008 | 5.89 Million USD | -59.59% |
| 2007 | 14.59 Million USD | -38.85% |
| 2006 | 23.86 Million USD | -36.93% |
| 2005 | 37.84 Million USD | -32.55% |
| 2004 | 56.11 Million USD | 61.79% |
| 2003 | 34.68 Million USD | -30.76% |
| 2002 | 50.08 Million USD | -20.62% |
| 2001 | 63.1 Million USD | 117.15% |
| 2000 | 29.05 Million USD | 511.26% |
| 1999 | 4.75 Million USD | -51.03% |
| 1998 | 9.7 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.37 Billion USD | -1.47% |
| 2024 Q3 | 6.74 Billion USD | 1.13% |
| 2024 Q2 | 6.67 Billion USD | 4.66% |
| 2023 Q2 | 6.35 Billion USD | 0.81% |
| 2023 FY | 6.47 Billion USD | 3.93% |
| 2023 Q4 | 6.47 Billion USD | 0.79% |
| 2023 Q3 | 6.42 Billion USD | 1.03% |
| 2023 Q1 | 6.3 Billion USD | 1.24% |
| 2022 Q3 | 6.3 Billion USD | -2.03% |
| 2022 Q1 | 6.49 Billion USD | -2.91% |
| 2022 Q4 | 6.22 Billion USD | -1.26% |
| 2022 FY | 6.22 Billion USD | -6.85% |
| 2022 Q2 | 6.43 Billion USD | -0.82% |
| 2021 Q2 | 6.72 Billion USD | -0.15% |
| 2021 Q4 | 6.68 Billion USD | 0.46% |
| 2021 FY | 6.68 Billion USD | 35.73% |
| 2021 Q3 | 6.65 Billion USD | -1.04% |
| 2021 Q1 | 6.73 Billion USD | 36.74% |
| 2020 FY | 4.92 Billion USD | 40.49% |
| 2020 Q1 | 4.46 Billion USD | 27.25% |
| 2020 Q2 | 4.46 Billion USD | 0.15% |
| 2020 Q3 | 4.35 Billion USD | -2.54% |
| 2020 Q4 | 4.92 Billion USD | 13.11% |
| 2019 Q3 | 1.75 Billion USD | -1.27% |
| 2019 Q2 | 1.78 Billion USD | 0.64% |
| 2019 FY | 3.5 Billion USD | 130.03% |
| 2019 Q4 | 3.5 Billion USD | 99.27% |
| 2019 Q1 | 1.77 Billion USD | 16.18% |
| 2018 Q2 | 1.48 Billion USD | 17.96% |
| 2018 Q3 | 1.5 Billion USD | 1.82% |
| 2018 FY | 1.52 Billion USD | 154.61% |
| 2018 Q1 | 1.25 Billion USD | 109.99% |
| 2018 Q4 | 1.52 Billion USD | 0.96% |
| 2017 Q3 | 587.17 Million USD | 0.79% |
| 2017 Q2 | 582.6 Million USD | 66.33% |
| 2017 Q1 | 350.26 Million USD | -7.1% |
| 2017 FY | 598.56 Million USD | 58.75% |
| 2017 Q4 | 598.56 Million USD | 1.94% |
| 2016 Q3 | 403.21 Million USD | 39.75% |
| 2016 Q1 | 323.78 Million USD | -11.12% |
| 2016 FY | 377.04 Million USD | 3.5% |
| 2016 Q4 | 377.04 Million USD | -6.49% |
| 2016 Q2 | 288.52 Million USD | -10.89% |
| 2015 Q3 | 393.98 Million USD | 55.72% |
| 2015 FY | 364.29 Million USD | 16.9% |
| 2015 Q4 | 364.29 Million USD | -7.54% |
| 2015 Q2 | 253.01 Million USD | -9.25% |
| 2015 Q1 | 278.81 Million USD | -10.53% |
| 2014 Q1 | 134.12 Million USD | -8.52% |
| 2014 FY | 311.62 Million USD | 112.53% |
| 2014 Q4 | 311.62 Million USD | 32.79% |
| 2014 Q3 | 234.66 Million USD | -8.26% |
| 2014 Q2 | 255.8 Million USD | 90.72% |
| 2013 Q1 | 99.99 Million USD | -10.82% |
| 2013 Q3 | 155.49 Million USD | -4.73% |
| 2013 Q4 | 146.62 Million USD | -5.7% |
| 2013 FY | 146.62 Million USD | 30.78% |
| 2013 Q2 | 163.21 Million USD | 63.22% |
| 2012 Q4 | 112.11 Million USD | -9.18% |
| 2012 FY | 112.11 Million USD | 15.64% |
| 2012 Q1 | 88 Million USD | -9.23% |
| 2012 Q2 | 76.08 Million USD | -13.55% |
| 2012 Q3 | 123.45 Million USD | 62.26% |
| 2011 Q2 | 85.49 Million USD | -6.29% |
| 2011 Q3 | 78.48 Million USD | -8.2% |
| 2011 Q4 | 96.95 Million USD | 23.52% |
| 2011 FY | 96.95 Million USD | 0.45% |
| 2011 Q1 | 91.23 Million USD | -5.47% |
| 2010 Q2 | 39.09 Million USD | 62.3% |
| 2010 Q4 | 96.51 Million USD | 168.3% |
| 2010 Q1 | 24.08 Million USD | -6.53% |
| 2010 FY | 96.51 Million USD | 274.52% |
| 2010 Q3 | 35.97 Million USD | -7.98% |
| 2009 Q1 | 21.97 Million USD | 272.6% |
| 2009 Q2 | 28.94 Million USD | 31.7% |
| 2009 Q3 | 27.96 Million USD | -3.36% |
| 2009 Q4 | 25.77 Million USD | -7.86% |
| 2009 FY | 25.77 Million USD | 336.93% |
| 2008 Q4 | 5.89 Million USD | -19.06% |
| 2008 Q3 | 7.28 Million USD | -23.58% |
| 2008 Q2 | 9.53 Million USD | -18.04% |
| 2008 Q1 | 11.63 Million USD | -20.29% |
| 2008 FY | 5.89 Million USD | -59.59% |
| 2007 Q2 | 19.39 Million USD | -8.95% |
| 2007 Q4 | 14.59 Million USD | -13.52% |
| 2007 Q3 | 16.87 Million USD | -12.97% |
| 2007 Q1 | 21.29 Million USD | -10.77% |
| 2007 FY | 14.59 Million USD | -38.85% |
| 2006 Q2 | 29.97 Million USD | -10.08% |
| 2006 Q3 | 26.57 Million USD | -11.35% |
| 2006 Q4 | 23.86 Million USD | -10.18% |
| 2006 FY | 23.86 Million USD | -36.93% |
| 2006 Q1 | 33.33 Million USD | -11.92% |
| 2005 FY | 37.84 Million USD | -32.55% |
| 2005 Q2 | 45.76 Million USD | -8.19% |
| 2005 Q1 | 49.85 Million USD | -11.15% |
| 2005 Q3 | 41.34 Million USD | -9.66% |
| 2005 Q4 | 37.84 Million USD | -8.47% |
| 2004 Q2 | 67.02 Million USD | -7.36% |
| 2004 Q4 | 56.11 Million USD | -8.74% |
| 2004 Q1 | 72.35 Million USD | 108.63% |
| 2004 FY | 56.11 Million USD | 61.79% |
| 2004 Q3 | 61.48 Million USD | -8.27% |
| 2003 Q4 | 34.68 Million USD | -18.21% |
| 2003 Q1 | 41.99 Million USD | -16.16% |
| 2003 FY | 34.68 Million USD | -30.76% |
| 2003 Q2 | 33.96 Million USD | -19.1% |
| 2003 Q3 | 42.4 Million USD | 24.82% |
| 2002 FY | 50.08 Million USD | -20.62% |
| 2002 Q4 | 50.08 Million USD | -13.21% |
| 2002 Q3 | 57.7 Million USD | -10.9% |
| 2002 Q2 | 64.77 Million USD | 13.79% |
| 2002 Q1 | 56.92 Million USD | -9.79% |
| 2001 Q2 | 71.07 Million USD | -5.86% |
| 2001 Q3 | 67.45 Million USD | -5.09% |
| 2001 Q4 | 63.1 Million USD | -6.46% |
| 2001 Q1 | 75.49 Million USD | 0.0% |
| 2001 FY | 63.1 Million USD | 117.15% |
| 2000 FY | 29.05 Million USD | 511.26% |
| 1999 FY | 4.75 Million USD | -51.03% |
| 1998 FY | 9.7 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -3178.202% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -47303.564% |
| Aspira Women's Health Inc. | 6.26 Million USD | -103242.926% |
| Biodesix, Inc. | 99.09 Million USD | -6430.369% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -56667.118% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -78611.83% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -78611.83% |
| Bionano Genomics, Inc. | 214.4 Million USD | -2918.29% |
| CareDx, Inc | 484.61 Million USD | -1235.356% |
| Check-Cap Ltd. | 25.01 Million USD | -25767.746% |
| Castle Biosciences, Inc. | 477.81 Million USD | -1254.371% |
| DarioHealth Corp. | 96.38 Million USD | -6613.768% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | -408.31% |
| Guardant Health, Inc. | 1.78 Billion USD | -262.251% |
| ICON Public Limited Company | 16.98 Billion USD | 61.911% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -98.512% |
| Illumina, Inc. | 10.11 Billion USD | 35.997% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -46865.66% |
| iSpecimen Inc. | 15.81 Million USD | -40808.262% |
| Standard BioTools Inc. | 323.06 Million USD | -1903.093% |
| MDxHealth SA | 129.13 Million USD | -4911.41% |
| 23andMe Holding Co. | 395.16 Million USD | -1537.62% |
| Medpace Holdings, Inc. | 1.65 Billion USD | -290.586% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -439.863% |
| Mainz Biomed B.V. | 15.4 Million USD | -41897.029% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -95712.764% |
| NeoGenomics, Inc. | 1.68 Billion USD | -284.917% |
| Neogen Corporation | 4.58 Billion USD | -41.167% |
| Inotiv, Inc. | 856.53 Million USD | -655.529% |
| Natera, Inc. | 1.45 Billion USD | -344.117% |
| OpGen, Inc. | 1.88 Million USD | -343704.037% |
| OPKO Health, Inc. | 2.01 Billion USD | -221.685% |
| Psychemedics Corporation | 13.27 Million USD | -48666.647% |
| Prenetics Global Limited | 254.17 Million USD | -2446.06% |
| Prenetics Global Limited | 254.17 Million USD | -2446.06% |
| Precipio, Inc. | 18.1 Million USD | -35651.251% |
| Personalis, Inc. | 225.09 Million USD | -2774.883% |
| RadNet, Inc. | 2.88 Billion USD | -124.178% |
| Sera Prognostics, Inc. | 95.44 Million USD | -6680.455% |
| Sotera Health Company | 3.13 Billion USD | -106.724% |
| Neuronetics, Inc. | 115.83 Million USD | -5486.876% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -7340.539% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -7340.539% |
| Trinity Biotech plc | 59.43 Million USD | -10788.086% |
| T2 Biosystems, Inc. | 34.79 Million USD | -18497.391% |
| Twist Bioscience Corporation | 776.4 Million USD | -733.502% |
| Exagen Inc. | 56.94 Million USD | -11264.383% |